Standing out in the field of IgY Immunotechnology

  • Home
    Home A full collection of all the Research Archive entries.
  • Years
    Years Sort entries by year.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Archives
    Archives Contains a list of research entries that were created previously.

IgY pharmacokinetics in rabbits: implications for IgY use as antivenoms.

Posted by on in 2014
  • Font size: Larger Smaller
  • Hits: 1045
  • Print
  • Díaz P1Malavé C2Zerpa N2Vázquez H3D'Suze G1Montero Y2Castillo C2Alagón A3Sevcik C4. 2014. Toxicon. 90:124-33. doi: 10.1016/j.toxicon.2014.07.021. Epub 2014 Aug 9.
  • 1Laboratory on Cellular Neuropharmacology, Centro de Biofísica y Bioquímica, Instituto Venezolano de Investigaciones Científicas (IVIC), Caracas, Venezuela.
  • 2Unidad de Neurociencias, Instituto de Estudios Avanzados (IDEA), Caracas, Venezuela.
  • 3Instituto de Biotecnología (IBt), Universidad Nacional Autónoma de México, Cuernavaca, Mexico.
  • 4Laboratory on Cellular Neuropharmacology, Centro de Biofísica y Bioquímica, Instituto Venezolano de Investigaciones Científicas (IVIC), Caracas, Venezuela. Electronic address: csevcik@ivic.gob.ve.

Abstract

This paper presents the first study of chicken IgY pharmacokinetics (PK) in rabbits. We measured IgY blood serum concentrations using a specific high sensitivity ELISA method. The fast initial component observed when studying horse Fab, F(ab')2 or IgG was absent from IgY PK. During the first 80 min of observation there was only a single slow exponential decay, which sped up afterward to the point that IgY became undetectable after 216 h of observation; due to this time course, PK parameters were determined with trapezoidal integration. The most significant IgY pharmacokinetic parameters determined were (all presented as medians and their 95% confidence interval): Area Under the Curve = 183.8 (135.2, 221.5) mg·h·L(-1); Distribution volume of the central compartment·[Body Weight (BW)](-1) = 46.0 (21.7, 70.3) mL·kg(-1); Distribution volume in steady state·BW(-1) = 56.8 (44.4, 68.5) mLkg(-1); Mean Residence Time = 40.1 (33.6, 48.5) h; Total plasma clearance·BW(-1) = 1.44 (1.15, 1.66) mL·h(-1)·kg(-1). Anti IgY IgG titers determined by ELISA increased steadily after 72 h, and reached 2560 (1920, 5760) dilution(-1) at 264 h; anti-chicken IgG concentrations rose up to 3.19 (2.31, 6.17) μg/mL in 264 h. Our results show that IgY PK lacks the fast initial decay observed in other PK studies using horse IgG, F(ab')2 or Fab, remains in the body 39.0 (28.7, 47.2) % much as IgG and is ≈3 times more immunogenic that horse IgG in rabbits.

Copyright © 2014 Elsevier Ltd. All rights reserved.

KEYWORDS:

Acquired immunity; Antivenoms; IgY; Pharmacokinetics

PMID:
 
25111201
 
[PubMed - in process]
Last modified on